MELVILLE, N.Y., Oct. 4, 2016 /PRNewswire/ -- Canon BioMedical is pleased to announce the launch of Novallele genotyping products in the United Kingdom and Ireland for sale through our distributor, Labtech. The Novallele portfolio covers genetic variations that can be difficult to genotype and offers a targeted approach for research laboratories to quickly obtain genotyping answers in their investigations.
“After receiving positive feedback at several scientific conferences in Europe, we are excited to share our solutions for DNA genotyping with researchers in the UK and Ireland” states Dennis Snyder, Senior Director of Global Commercial Operations for Canon BioMedical. “We look forward to working with Labtech, a qualified distributor with numerous years of experience serving the research communities in these countries.”
Since launching our first Novallele genotyping products in September of last year, Canon BioMedical has expanded the assay menu to include multiple new targets. The assays provide unique solutions for mitochondrial DNA and large deletions while supporting a wide variety of research areas, such as pharmacogenetics, cancer, and inherited disease. The full menu of 281 genotyping assays and complementary high-speed chemistry reagents are now offered in the United Kingdom and Ireland.
The Novallele genotyping assays detect genetic variations using polymerase chain reaction (PCR) followed by high-resolution melting (HRM) analysis on any thermocycler capable of HRM. In addition to a large number of SNP targets, there are also assays available for genotyping small and large insertions and deletions.
The Novallele genotyping assays and reagents are now available to customers in the United Kingdom and Ireland for purchase through Labtech at www.labtech.com. Our customers in the United States should continue to visit www.canon-biomedical.com.
About Labtech
Labtech was established in January 1993 as a supplier and service provider for highly innovative scientific equipment and consumables. Labtech supports this technology-based portfolio with a highly qualified team of customer focused application specialists and a very experienced service department. In this way, Labtech not only provides state-of-the-art tools to life scientists but also provides high level application, service, and calibration support to our customers in the laboratory.
About Canon BioMedical
Canon BioMedical, a wholly owned subsidiary of Canon U.S.A., Inc., is focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions. The technologies and solutions developed will help enable clinicians and scientists to improve our health and advance science. Canon BioMedical will continue to pursue innovative solutions in line with Canon’s Kyosei philosophy of social and environmental responsibility through the use of existing and emerging Canon technology as well as strategic partnerships.
Products mentioned in this release are for Research Use Only. Not for use in diagnostic procedures.
All referenced product names, and other marks, are trademarks of their respective owners.
© 2016 Canon BioMedical, Inc. All rights reserved.
Logo - http://photos.prnewswire.com/prnh/20160119/323578LOGO
Canon BioMedical | 1-844-CANONBIO |
One Canon Park | (1-844-226-6624) |
Melville, NY 11747 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/canon-biomedical-products-launched-in-the-united-kingdom-and-ireland-300338997.html
SOURCE Canon BioMedical
